Menu

Resources

Displaying 1 - 10 of 21 results.

Material Proximities and Hotspots: Toward an Anthropology of Viral Hemorrhagic Fevers

This resource outlines a research program for an anthropology of viral hemorrhagic fevers and reviews the social science literature on Ebola, Marburg, and Lassa fevers and charts areas for future ethnographic attention. The paper suggests that attention to the material proximities between animals, humans, and objects, that constitute the "hotspot", opens a frontier for critical and methodological development in medical anthropology and for future collaborations in viral hemorrhagic fever management and control.

Read more
Learn more about this resource.

Lassa fever is unheralded problem in West Africa

This resource describes primary and secondary transmission of Lassa fever and barrier nursing techniques as a means to prevent this.

Read more
Learn more about this resource.

Nigeria Centre for Disease Control (NCDC): Viral haemorrhagic fever factsheet

This factsheet provides information on viral haemorrhagic fevers from the Nigeria Centre for Disease Control.

Read more
Learn more about this resource.

Lassa fever in post-conflict Sierra Leone

This resource presents observations of case fatality rates of Lassa fever in Sierra Leone after the civil war and compared to studies completed prior to the conflict. Peak presentation of Lassa fever cases occurs in the dry season, which is consistent with previous studies. This paper's studies also confirmed reports conducted prior to the civil war that indicate that infants, children, young adults, and pregnant women are disproportionately impacted by Lassa fever.

Read more
Learn more about this resource.

Lassa fever in West Africa: Evidence for an expanded region of endemicity

This resource presents evidence for an expanded endemicity zone between the two known Lassa endemic regions indicating that Lassa virus is more widely distributed throughout the Tropical Wooded Savanna ecozone in West Africa.

Read more
Learn more about this resource.

World Health Organisation (WHO): Lassa fever

This is the WHO emergencies website page for Lassa fever.

Read more
Learn more about this resource.

Organizing the donation of convalescent plasma for a therapeutic clinical trial on Ebola Virus Disease: The experience in Guinea

This resource reports on the successful organization of donor mobilization and plasma collection as part of the Ebola-Tx clinical trial from November 2014 to July 2015 in Conakry, Guinea, the challenges they faced, and efforts made to address these.

Read more
Learn more about this resource.

Lassa fever: The politics of an emerging disease and the scope for One Health

As a rodent borne virus, Lassa fever is of particular interest from a One Health perspective. The interplay between security, public health and One Health approaches are explored through ethnographic and interview based research in Kenema, Sierra Leone, a long-term treatment and research hub. ‘Biodefence dollars’ have provided the majority of recent funding in Sierra Leone and have created opportunities for both local and international actors to address a neglected disease.

Read more
Learn more about this resource.

Shadowlands and dark corners: An anthropology of light and zoonosis

This paper outlines the importance of the house construction and the light for the human and rodent interactions in Upper Guinea (Guinea). To address this interspecies entanglements it is necessary to have in mind how darkness created by furniture and the house design can expand the activity of the animal and the persistence of virus in surfaces. It also highlights the difficulty to localize the trapping of small rodents by kids.

Read more
Learn more about this resource.

Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa

This resource describes the main challenges of the implementation of a trial in the Ebola treatment center of Guéckédou. Following the principles of the Good Clinical Research Practices, it reports the aspects of the community’s communication and engagement, ethical conduct, trial protocol compliance, informed consent of participants, ongoing benefit/risk assessment, record keeping, confidentiality of patients and study data, and roles and responsibilities of the actors involved.

Read more
Learn more about this resource.
Subscribe to Resources